Home » Viragen, Inc. Announces European Multiferon Licensing Agreement
Viragen, Inc. Announces European Multiferon Licensing Agreement
Viragen,
Inc. and its majority-owned subsidiary, Viragen International, Inc., announced
that a licensing agreement has been completed with Swedish Orphan International
AB, granting exclusive marketing rights to Multiferon (multi-subtype, human alpha
interferon) for the European Union (excluding previously licensed member states).
BioSpace
Upcoming Events
-
07May
-
14May
-
30May